# Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therapeutics/adf9cb72-5955-4d5f-8f26-4e226281ace9

> FDA guidance document: Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics. Issue date: March 24, 2023. Get complete insights and analysis.

---

## Details

- Title: Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics
- Communication Type: Guidance Document
- Product Type: other
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2023-03-24
- Comment Close Date: 2023-05-26
- Last Changed: 2023-03-27
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-0110">FDA-2023-D-0110</a>

## Related Documents

- [Tissue Agnostic Drug Development in Oncology: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/tissue-agnostic-drug-development-in-oncology-draft-guidance-for-industry/3835823e-c995-46e5-98c7-9422ad94971f)
- [Accelerated Approval and Considerations for Determining Whether a Confirmatory Trial is Underway](https://www.globalkeysolutions.net/guidances/guidance-document/accelerated-approval-and-considerations-for-determining-whether-a-confirmatory-trial-is-underway/ae83d008-58ac-4e99-bb05-ca1492236392)
- [Considerations for Generating Clinical Evidence from Oncology Multiregional Clinical Development Programs](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-generating-clinical-evidence-from-oncology-multiregional-clinical-development-programs/78fa8deb-dab7-4321-a08d-f5971e107619)